Algeta ASA : Algeta Results for the Third Quarter 2013

02:01 EST 6 Nov 2013 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Preview:
Not intended for US media Oslo, Norway, 6 November 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces its results for the third quarter 2013. A presentation of the results in Os...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Algeta ASA : Algeta Results for the Third Quarter 2013"

Search BioPortfolio:
Loading
Advertisement

Relevant Topics

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs.  Cancer sometimes begins in one part of the body before spre...

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story